😰 Stocks Fall and Oil Surges After Israel and Iran Fire Missiles

Plus, Apple falls 4% after new announcements, Elon apologizes, Chime soars 70% on IPO, and more...

TOP STORY
😰 Stocks Fall and Oil Surges After Israel and Iran Fire Missiles

😰 Last week, we covered the ā€˜war of words’ between Trump and Elon Musk, but today we’ll unfortunately be covering a real war brewing in the Middle East that caused markets to fall this week:

  • The S&P 500 fell -0.5% over the week and -1.1% on Friday

  • The Nasdaq-100 fell -0.7% over the week and -1.3% on Friday

  • Oil soared with Global X’s Crude Oil ETF ($HUC) jumping +8.3% this week and +4.5% on Friday

šŸ¤” So what happened? On Friday, Israel launched a ā€œhistoric and significant strike on Iran’s nuclear facilitiesā€. Iran hit back Friday evening, firing hundreds of ballistic missiles at Israeli military centers.

The conflict escalated into the weekend with Israeli Defence Minister saying Iran’s counter-attack had ā€œcrossed the red lineā€, adding:

ā

ā€œIf (Supreme Leader Ayatollah Ali) Khamenei continues to fire missiles at the Israeli home front, Tehran will burn."

Israeli Defence Minister Israel Katz

So before we dive into some of the other stories this week (from Apple $AAPL falling 4% after ā€˜underwhelming announcements’ at its developer conference to Tesla $TSLA soaring +14% after Elon’s apology to Trump), let’s cover the impact of the escalating conflict on the stock market:

šŸ¤·šŸ»ā€ā™€ļø Investors Seem to Largely Be Shrugging Off the Conflict

According to Bloomberg, Thursday and Friday’s events are ā€œthe kind of geopolitical flashpoint that might once have triggered a full-blown market meltdownā€, but with all the chaos in recent months, the impact was fairly minor.

As you can see in the chart below, compared to the big swings seen back in April, the ups and downs in the S&P 500 are pretty par for the course.

šŸŽ¢ In a way, all the wild swings have trained investors not to stress too much about the news. All the selloffs so far this year have been short-lived and rewarded dip-buyers, increasing investor excitement and confidence in the markets.

šŸ§˜ā€ā™€ļø Why Long-Term Investors Shouldn’t Be Worried

And in case you’re a new investor feeling stressed about conflict (or any of the recent big swings for that matter), I was planning to share this chart, but saw @bdinvesting already beat me to the punch:

If you're investing for the long haul, wars, disease, tariffs, geopolitical events, and other ā€˜market-shocks’ are part of the game, and while unfortunate, are really just ā€˜noise’ as BD puts it.

āš ļø Swing Traders Should Be Cautious

Now, if you’re investing for the short-term, or stock-picking individual stocks, Friday’s events may be a bit of a different story, and Franklin Templeton’s Chief Investment Officer Max Gokhman issues a word of caution:

ā

ā€œThis has been a year where fading bad news paid off, and the FOMO theme has been growing louder. When that momentum becomes blind euphoria it can cause bulls to hit a brick wall at full speedā€

Franklin Templeton’s Chief Investment Officer, Max Gokhman

This conflict is still in its infancy, and with Israel warning that its attacks may go on for weeks, the market will certainly be put to the test.

šŸ’° Some investors may see the chaos as an opportunity (for instance, by buying defence stocks like Lockheed Martin $LMT - which rose +3.7% of Friday, or a leveraged oil ETF like $HOU - which rose +13.3% on Friday, in the expectation that the conflict will escalate), but just know if you’re doing that, you are making more of a ā€˜bet’ on uncertain events and should proceed with caution!

Ok, let’s switch gears to some of the other big stock market news this week, but first a quick word from today’s sponsor Harvest ETFs!

PRESENTED BY HARVEST ETFs
ā­ļø HHIS | One ETF. Multiple Opportunities & MSTE | MicroStrategy with Monthly Income

šŸ“ˆ The top US companies offer access to the growth of AI, the Bitcoin boom, a revolution in weight-loss drugs, chipmakers, and more. Access these opportunities with one ETF.

šŸŒŽ The Harvest Diversified High Income Shares ETF (HHIS:TSX) provides exposure to top US companies through single stock ETFs – Harvest High Income Shares. The underlying ETFs employ an active covered call strategy and modest leverage to generate high monthly cash distributions.

. . . And are you hungry for exposure to the Bitcoin boom?

šŸ’ø The Harvest MicroStrategy Enhanced High Income Shares ETF (MSTE:TSX) invests all its assets, directly or indirectly, in Class A shares of MicroStrategy (MSTR). MSTR has developed into a Bitcoin treasury company, with substantial holdings in the world’s top cryptocurrency.

šŸ¤ On top of access to MSTR, Harvest writes covered calls and employs modest leverage, aiming to generate high monthly cash distributions.

*See Harvest Disclaimer at the end of the newsletter

ALSO IN THE NEWS
šŸ—žļø Other Key Headlines this Week

šŸŽ Apple Falls 4% After Underwhelming Developer Conference

  • Apple’s stock ($AAPL) dropped by -4% after a muted reaction to Apple’s Developer Conference, which showed limited AI advancements and slow Siri progress, with Apple confirming its Siri AI overhaul would be delayed until at least 2026.

  • Apple’s new ā€œLiquid Glassā€ interface, featuring translucent widgets, smoother animations, and more dynamic home screen elements, was notable but was not enough to offset the delays in Apple’s AI roadmap.

  • Other new features include Workout Buddy (an AI fitness coach), smart replies in Messages, on-device translation in Safari, iPhone call screening, and ChatGPT-powered image generation in Notes and Mail.

  • Analysts say Apple’s cautious, privacy-first AI strategy is losing momentum against aggressive competitors like Google and OpenAI, with a broader media narrative that it’s falling behind.

  • In a surprising move, Apple has also started taking shots at the AI industry as a whole, releasing a research paper that shows ā€œtop-tier AI models collapse in reasoning accuracy when facing complexity, describing it as "an illusion of thinking."

šŸ“ˆ Fintech App Chime Surges 70% on IPO

  • Fintech App Chime ($CHYM) IPO’ed this week with the stock soaring +70% above its $27 IPO price, opening at $43 and valuing the company at $15.7 billion before falling back down to ~$35 to end the week.

  • The app’s no-fee banking model, with features like SpotMe overdraft protection and MyPay early paycheck access, has resonated with younger, underserved customers earning under $100k/year.

  • Chime boasts ~8.6 million active users, and grew revenue over 30% YoY in 2024 to $1.67B, hitting profitability in Q1 despite a $25 million 2024 loss.

  • Analysts view Chime’s strong debut (along with recent IPOs from eToro, Webull, and Circle) as a sign for fintech IPOs returning.

  • Over 139 Blossom users now hold the stock with Chime ranking as the #90 Most Bought stock this week.

ā­ļø Quantum Stocks Soar After Nvidia CEO Says Quantum Computing Has Reached ā€œAn Inflection Pointā€

  • This Wednesday Nvidia CEO Jensen Huang said quantum computing is now at an ā€œinflection point,ā€ suggesting it could start solving complex real-world problems in the coming years, a sharp reversal from his earlier view that the technology was still 15 to 30 years away (that previously tanked the Quantum market).

  • Quantum Computing ($QUBT) surged +25% and Rigetti ($RGTI) and IonQ ($IONQ) both jumped +11% following Huang’s comments on Wednesday (but many have since fallen back down).

  • Nvidia highlighted its growing partnerships in quantum research, like hybrid quantum-classical Cuda‑Q and collaborations with firms like Quantinuum, reinforcing its commitment to the space.

  • The broader quantum sector rally reflects renewed investor optimism, especially as major players like IBM, IonQ, and D-Wave advance error correction, funding, and infrastructure initiatives.

🚘 Tesla Jumps 14% After Elon Publicly Apologizes to Trump

  • Tesla stock jumped +14% after Elon Musk publicly apologized to Donald Trump following last week’s online feud over Trump’s ā€œBig Beautiful Bill,ā€ which is set to cut EV rebates.

  • Musk tweeted, ā€œI regret some of my posts… they went too farā€, following a private call with Trump aimed at easing tensions.

  • Tesla had fallen a massive -21% from the public dispute, driven by fears of political retaliation. Tesla is still down ~9% since the public fight began.

  • Analysts say the apology could reduce near-term risks but caution that tensions could resurface.

PRESENTED BY CIBC
šŸŒŽ CDRs, Your Passport to Global Stocks

šŸ“Š CDRs provide exposure to shares of global companies but they're traded in Canadian dollars on a Canadian exchange. Over 100 of the best known global companies, like Nvidia, Lululemon, and ASML are now available as CDRs and cost a fraction of the share price. And the best part? No need to convert your Canadian dollars to foreign currencies in order to get exposure to US and European companies.

šŸŽÆ CDRs provide you with the following benefits, when compared to buying shares of a foreign company directly:

  • No currency conversion: CDRs trade in Canadian dollars, so you don't need to factor currency conversion into your investment decisions. Any dividends that are paid on the reference shares will be also be paid to CDR investors in Canadian dollars.

  • Managing FX exposure and risk: The built-in notional currency hedge mitigates the currency risk associated with foreign investing. This means that the investment returns depend on the performance of the underlying shares, and not the currency in which it is traded.

šŸ CIBC’s CDRs are made for Canadians, by Canadians.

*See CIBC CDRs Disclaimer at the end of the newsletter

IN PARTNERSHIP WITH CBOE CANADA
🚨 New Listing Alert! Onco-Innovations Uplists to CBOE Canada

šŸ„ While this section of the Buzz is normally dedicated to new ETF listings, this week it’s a stock that made headlines at CBOE after Onco-Innovations Limited ($ONCO), a Canadian-based company dedicated to cancer research and treatment, uplisted to Cboe Canada.

🧪 Onco has a core mission to prevent and cure cancer through cutting-edge science. The company holds an exclusive global license to patented technology targeting solid tumors, and is now expanding into AI-driven analytics for multimodal real-world data. Onco is focused on advancing personalized therapies that improve cancer outcomes and set new standards in oncology research.

According to Onco’s CEO, the uplisting marks an important step for the company:

ā

ā€œJoining Cboe is more than a listing, it’s a strategic alignment. It gives us the tools to deepen investor engagement, expand our network, and accelerate our journey toward transforming the future of cancer therapy.ā€

Thomas O’Shaughnessy, CEO of Onco

FROM THE BLOSSOM COMMUNITY
ā­ļø Featured Discussions this Week

šŸ‘‡ Click to see the full post!

Harvest Disclaimer:

Commissions, management fees and expenses all may be associated with investing in Harvest Exchange Traded Funds (managed by Harvest Portfolios Group Inc.). Please read the relevant prospectus before investing. The Funds are not guaranteed, their values change frequently, and past performance may not be repeated. Distributions are paid to you in cash unless you request, pursuant to your participation in a distribution reinvestment plan, that they be reinvested into available Class units of the Funds. If the Funds earn less than the amounts distributed, the difference is a return of capital.

CIBC Disclaimer:

This ad is provided for general informational purposes only and does not constitute financial, investment, tax, legal or accounting advice nor does it constitute an offer or solicitation to buy or sell any securities referred to. Please read the CIBC Canadian Depositary Receipts (CDRs) prospectus, including the risk factors therein, before investing. To obtain a copy, visit cdr.cibc.com. CDRs are not guaranteed, their values change frequently and past performance may not be repeated. Certain expenses may be associated with CDR investments. The issuance of CDRs is not a financing for the benefit of issuers of the shares underlying CDRs (Underlying Issuers) and Underlying Issuers will not receive any proceeds from the offering and sale of CDRs. The Underlying Issuers have not participated in the preparation of the prospectus or this article, do not take any responsibility or assume any liability with respect to the accuracy or completeness of any information therein and make no representation regarding the advisability of purchasing any CDRs. Ā®The CIBC logo and ā€œCIBC Capital Marketsā€ are registered trademarks of CIBC, used under license.